Cross-sectional evaluation of the metabolic vulnerability index in heart failure populations
This study highlights significant differences in MVX distribution and its clinical correlates between a clinical trial and a community cohort despite matched heart failure subtypes. These findings have important implications for interpreting and applying the score in diverse study settings.
Authors
- Margery A. Connelly (ORCID: https://orcid.org/0000-0002-3917-592X)
- Suzette J. Bielinski (ORCID: https://orcid.org/0000-0002-2905-5430)
- Véronique L. Roger (ORCID: https://orcid.org/0000-0002-9347-7865)
- Kayode O. Kuku (ORCID: https://orcid.org/0000-0003-3366-0702)
- Jungnam Joo (ORCID: https://orcid.org/0000-0001-6961-8122)
- Joseph J. Shearer (ORCID: https://orcid.org/0000-0002-1443-7428)
- Alan T. Remaley (ORCID: https://orcid.org/0000-0003-2473-5549)
Institutions
- National Institutes of Health (US)
- LabCorp (United States) (US)
- National Heart, Lung, and Blood Institute (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1186/s12872-025-04758-w
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases